KELSEY MORKEM: Open Payments
NPI 1043977986 · GAINESVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,957 in 78 payments from 19 companies in 2025. Trend: 2023 $1,846 · 2024 $1,164 · 2025 $1,957
Food & beverage: $1,857Education: $100
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $369 |
| Axsome Therapeutics, Inc. | 4 | $272 |
| Lilly USA, LLC | 9 | $260 |
| Astellas Pharma US Inc | 6 | $216 |
| Amgen Inc. | 5 | $179 |
| ABBVIE INC. | 15 | $157 |
| Ardelyx, Inc. | 9 | $142 |
| Lundbeck LLC | 2 | $59 |
| Evofem Biosciences, Inc. | 3 | $58 |
| Radius Health, Inc. | 2 | $47 |
Products named: Wegovy, Auvelity, ZEPBOUND, IBSRELA, EVENITY, Veozah, VRAYLAR, MOUNJARO.
Industry payments across GA — which companies pay providers there.
